Clinical Trials Directory

Trials / Completed

CompletedNCT02664974

Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer

Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer: A Multicenter Randomized Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
79 (actual)
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Phase III, medical, multicentric, controlled, open label, two-parallel groups, randomized, clinical trial. The aim of this study is to evaluate the efficacy of home enteral nutrition on the nutritional status, the quality of life and tolerance to chemotherapy, in malnourished patients who undergo major gastrointestinal surgery for malignancy (oesophagus, stomach, pancreas, biliary tract). Patients were randomized to receive either home enteral nutrition (HEN, treatment group) or nutritional counselling (control group).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnteral nutritionHome Enteral Nutrition was planned to cover the basal energy requirement calculated with Harris Benedict Formula, it was administrated preferentially during nocturnal hours as an integration of oral diet. Enteral Nutrition included any standard polymeric formula providing 1-1.5 Kcal/mL with carbohydrates 50%-60%, lipids 25%-35% and protein 12%-20%. Home Enteral Nutrition can be withdrawn in the treated group, after 2 months from discharge, whenever a weight gain ≥ 5% is reported, and oral alimentation is regular and adequate.
OTHERDietary counselingSpecific nutritional advices including total energy and protein requirements were provided to patients and oral high-calorie supplements were prescribed whenever necessary. Home Enteral Nutrition can be started in patients of the control group, not before two months from discharge, if a further weight loss ≥ than 5% is reported.

Timeline

Start date
2008-12-01
Primary completion
2011-02-01
Completion
2011-06-01
First posted
2016-01-27
Last updated
2016-01-27

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02664974. Inclusion in this directory is not an endorsement.